Stocks were fluctuating in intraday trading on Tuesday, with the Dow picking up steam following Pfizer's U.K. vaccine rollout.
The U.K. approved the Pfizer and BioNTech vaccine and started to distribute it starting this morning.
The U.S. Food and Drug Administration is meeting later this week to decide whether or not to grant Pfizer and BioNTech's vaccine an Emergency Use Authorization. If the FDA does approve the vaccine, then distribution in the country could begin within 24 hours, according to Health and Human Services Secretary Alex Azar.
The U.S. said it would have enough COVID-19 vaccine doses to let most Americans get inoculated by the summer. The New York Times reported that federal officials last summer turned down an offer from Pfizer to sell the country more doses of its vaccine.
Latest Videos From TheStreet and Jim Cramer:
- Coronavirus: The Latest Numbers on the COVID-19 Pandemic
- What Home Office Tells Jim Cramer About What Comes After Dow 30,000
- Drivers of Disruption and Innovation in the PPE Space
- Why Jim Cramer Is Confident on a Vaccine Rollout
- Jim Cramer: How to Balance Stay-At-Home and Return to Normal Plays